140 related articles for article (PubMed ID: 27881062)
41. Assessing Optimal Blood Pressure in Patients With Asymptomatic Aortic Valve Stenosis: The Simvastatin Ezetimibe in Aortic Stenosis Study (SEAS).
Nielsen OW; Sajadieh A; Sabbah M; Greve AM; Olsen MH; Boman K; Nienaber CA; Kesäniemi YA; Pedersen TR; Willenheimer R; Wachtell K
Circulation; 2016 Aug; 134(6):455-68. PubMed ID: 27486164
[TBL] [Abstract][Full Text] [Related]
42. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
43. Vitamin D(2) supplementation induces the development of aortic stenosis in rabbits: interactions with endothelial function and thioredoxin-interacting protein.
Ngo DT; Stafford I; Kelly DJ; Sverdlov AL; Wuttke RD; Weedon H; Nightingale AK; Rosenkranz AC; Smith MD; Chirkov YY; Kennedy JA; Horowitz JD
Eur J Pharmacol; 2008 Aug; 590(1-3):290-6. PubMed ID: 18585377
[TBL] [Abstract][Full Text] [Related]
44. Progression of aortic valve sclerosis and aortic valve stenosis: what is the role of statin treatment?
Antonini-Canterin F; Popescu BA; Huang G; Korcova-Miertusova R; Rivaben D; Faggiano P; Pavan D; Piazza R; Bolis A; Ciavattone A; Ruggiero A; Nicolosi GL
Ital Heart J; 2005 Feb; 6(2):119-24. PubMed ID: 15819504
[TBL] [Abstract][Full Text] [Related]
45. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS
Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
[TBL] [Abstract][Full Text] [Related]
46. Understanding the structural features of symptomatic calcific aortic valve stenosis: A broad-spectrum clinico-pathologic study in 236 consecutive surgical cases.
Galli D; Manuguerra R; Monaco R; Manotti L; Goldoni M; Becchi G; Carubbi C; Vignali G; Cucurachi N; Gherli T; Nicolini F; Lorusso R; Vitale M; Corradi D
Int J Cardiol; 2017 Feb; 228():364-374. PubMed ID: 27866029
[TBL] [Abstract][Full Text] [Related]
47. Hypertension in aortic coarctation.
Hager A
Minerva Cardioangiol; 2009 Dec; 57(6):733-42. PubMed ID: 19942845
[TBL] [Abstract][Full Text] [Related]
48. Time to treat hypertension in patients with aortic stenosis.
Lindman BR; Otto CM
Circulation; 2013 Sep; 128(12):1281-3. PubMed ID: 23956212
[No Abstract] [Full Text] [Related]
49. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
50. Response to letters regarding article, "systemic hypertension in low-gradient severe aortic stenosis with preserved ejection fraction".
Eleid MF; Nishimura RA; Sorajja P; Borlaug BA
Circulation; 2014 Jul; 130(1):e6. PubMed ID: 24982126
[No Abstract] [Full Text] [Related]
51. Letter by Laskey regarding article, "systemic hypertension in low-gradient severe aortic stenosis with preserved ejection fraction".
Laskey W
Circulation; 2014 Jul; 130(1):e4. PubMed ID: 24982124
[No Abstract] [Full Text] [Related]
52. Patterns of antihypertensive therapy among patients with diabetes.
Johnson ML; Singh H
J Gen Intern Med; 2005 Sep; 20(9):842-6. PubMed ID: 16117753
[TBL] [Abstract][Full Text] [Related]
53. [Arterial hypertension in children and adolescents].
Seeman T
Cas Lek Cesk; 2006; 145(8):625-32; discussion 632-4. PubMed ID: 16995418
[TBL] [Abstract][Full Text] [Related]
54. Letter by Dumesnil and Pibarot regarding article, "systemic hypertension in low-gradient severe aortic stenosis with preserved ejection fraction".
Dumesnil JG; Pibarot P
Circulation; 2014 Jul; 130(1):e5. PubMed ID: 24982125
[No Abstract] [Full Text] [Related]
55. Development and trends in the drug treatment of essential hypertension.
van Zwieten PA
J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322
[TBL] [Abstract][Full Text] [Related]
56. Trends in antihypertensive treatment--lessons from the National Acute Stroke Israeli (NASIS) registry.
Koifman E; Tanne D; Molshatzki N; Leibowitz A; Grossman E
Blood Press; 2014 Oct; 23(5):262-9. PubMed ID: 24483945
[TBL] [Abstract][Full Text] [Related]
57. A novel mouse model of aortic valve stenosis induced by direct wire injury.
Honda S; Miyamoto T; Watanabe T; Narumi T; Kadowaki S; Honda Y; Otaki Y; Hasegawa H; Netsu S; Funayama A; Ishino M; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Miyashita T; Kubota I
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):270-8. PubMed ID: 24311378
[TBL] [Abstract][Full Text] [Related]
58. Simultaneous operative correction of aortic valve stenosis and idiopathic hypertrophic subaortic stenosis.
Stewart S; Nanda N; DeWeese J
Circulation; 1975 Aug; 52(2 Suppl):I34-9. PubMed ID: 1171737
[TBL] [Abstract][Full Text] [Related]
59. Pharmacological rationale for antihypertensive drug treatment.
Prichard BN
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S6-17. PubMed ID: 2454370
[TBL] [Abstract][Full Text] [Related]
60. Antihypertensive treatment and risk of atrial fibrillation: a nationwide study.
Marott SC; Nielsen SF; Benn M; Nordestgaard BG
Eur Heart J; 2014 May; 35(18):1205-14. PubMed ID: 24347316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
